Biotech company enGene to raise $200m in private placement

EnGene Holdings is a Montreal-based biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs.

ByIrien Joseph

14 February 2024•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Canada North America Healthcare Briefs

Biotech company enGene to raise $200m in private placement

Commodore Capital

Cormorant Asset Management

Foresite Capital Management

Janus Henderson Investors

Logos Capital

Related articles